These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15293284)

  • 1. Functional significance of S6K overexpression in meningioma progression.
    Surace EI; Lusis E; Haipek CA; Gutmann DH
    Ann Neurol; 2004 Aug; 56(2):295-8. PubMed ID: 15293284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells.
    Kliese N; Gobrecht P; Pachow D; Andrae N; Wilisch-Neumann A; Kirches E; Riek-Burchardt M; Angenstein F; Reifenberger G; Riemenschneider MJ; Meese E; Panayotova-Dimitrova D; Gutmann DH; Mawrin C
    Oncogene; 2013 Sep; 32(39):4712-20. PubMed ID: 23108408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
    Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
    Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
    Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTORC1 inhibitors suppress meningioma growth in mouse models.
    Pachow D; Andrae N; Kliese N; Angenstein F; Stork O; Wilisch-Neumann A; Kirches E; Mawrin C
    Clin Cancer Res; 2013 Mar; 19(5):1180-9. PubMed ID: 23406776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro.
    Bajetto A; Barbieri F; Pattarozzi A; Dorcaratto A; Porcile C; Ravetti JL; Zona G; Spaziante R; Schettini G; Florio T
    Neuro Oncol; 2007 Jan; 9(1):3-11. PubMed ID: 17108064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PS6K amplification characterizes a small subset of anaplastic meningiomas.
    Cai DX; James CD; Scheithauer BW; Couch FJ; Perry A
    Am J Clin Pathol; 2001 Feb; 115(2):213-8. PubMed ID: 11211609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factor in human meningiomas and peritumoral brain areas.
    Ding YS; Wang HD; Tang K; Hu ZG; Jin W; Yan W
    Ann Clin Lab Sci; 2008; 38(4):344-51. PubMed ID: 18988927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the cell lines used in meningioma research.
    Ragel BT; Couldwell WT; Gillespie DL; Wendland MM; Whang K; Jensen RL
    Surg Neurol; 2008 Sep; 70(3):295-307; discussion 307. PubMed ID: 18261772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.
    Ragel BT; Jensen RL; Gillespie DL; Prescott SM; Couldwell WT
    Cancer; 2007 Feb; 109(3):588-97. PubMed ID: 17177201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl2 and ROS1 expression in human meningiomas: an analysis with respect to histological subtype.
    Girish V; Sachdeva N; Minz RW; Radotra B; Mathuria SN; Arora SK
    Indian J Pathol Microbiol; 2005 Jul; 48(3):325-30. PubMed ID: 16761743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and structure of interleukin 4 receptors in primary meningeal tumors.
    Puri S; Joshi BH; Sarkar C; Mahapatra AK; Hussain E; Sinha S
    Cancer; 2005 May; 103(10):2132-42. PubMed ID: 15830341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transmembrane chemokines CXCL16 and CX3CL1 and their receptors are expressed in human meningiomas.
    Li G; Hattermann K; Mentlein R; Mehdorn HM; Held-Feindt J
    Oncol Rep; 2013 Feb; 29(2):563-70. PubMed ID: 23229614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative genomic analysis identifies CCNB1 and CDC2 as candidate genes associated with meningioma recurrence.
    Bie L; Zhao G; Ju Y; Zhang B
    Cancer Genet; 2011 Oct; 204(10):536-40. PubMed ID: 22137483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of an in vivo meningioma model with human telomerase reverse transcriptase.
    Cargioli TG; Ugur HC; Ramakrishna N; Chan J; Black PM; Carroll RS
    Neurosurgery; 2007 Apr; 60(4):750-9; discussion 759-60. PubMed ID: 17415213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line.
    Kondraganti S; Gondi CS; Gujrati M; McCutcheon I; Dinh DH; Rao JS; Olivero WC
    Int J Oncol; 2006 Jul; 29(1):25-32. PubMed ID: 16773181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro.
    Ragel BT; Gillespie DL; Kushnir V; Polevaya N; Kelly D; Jensen RL
    Neurosurgery; 2006 Nov; 59(5):1109-20; discussion 1120-1. PubMed ID: 17143245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study.
    Loussouarn D; Brunon J; Avet-Loiseau H; Campone M; Mosnier JF
    Hum Pathol; 2006 Apr; 37(4):415-21. PubMed ID: 16564915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression.
    Sayagués JM; Tabernero MD; Maíllo A; Trelles O; Espinosa AB; Sarasquete ME; Merino M; Rasillo A; Vera JF; Santos-Briz A; de Alava E; Garcia-Macias MC; Orfao A
    J Neuropathol Exp Neurol; 2006 May; 65(5):445-54. PubMed ID: 16772868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NDRG4, the N-Myc downstream regulated gene, is important for cell survival, tumor invasion and angiogenesis in meningiomas.
    Kotipatruni RP; Ferraro DJ; Ren X; Vanderwaal RP; Thotala DK; Hallahan DE; Jaboin JJ
    Integr Biol (Camb); 2012 Oct; 4(10):1185-97. PubMed ID: 22869042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.